Guardian Biotechnologies
From Wikipedia, the free encyclopedia
| Guardian Biotechnologies Inc. | |
|---|---|
| Type | Private |
| Founded | August 2002 |
| Headquarters | Saskatoon, Saskatchewan, Canada |
| Key people | Sun Lee (CEO), Jim MacPherson (R&D Director) |
| Industry | Plant biotechnology, Molecular farming (Plant-made pharmaceuticals) |
| Products | Poultry vaccine for coccidiosis, Phase 2 trails (Canada) [1] |
| Parent | Nexgen Biotechnologies Inc., Korea |
| Website | http://www.guardianbio.com |
| As on 27 October 2006 | |
Launched in August 2002, Guardian Biotechnologies Inc. is a privately owned plant biotechnology company that operates from its corporate headquarters in Saskatoon, Saskatchewan, Canada.
[edit] References
- ^ Fox, Jeffrey L (1 October 2006,). "Turning plants into protein factories". Nature Biotechnology 24: 1191–1193. doi:.
[edit] External links
- Official website
- Profile on NRC-Plant Biotechnology Institute's bulletin
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
 This article about a Canadian corporation or company is a stub. You can help Wikipedia by expanding it. |
 |
This Saskatchewan-related article is a stub. You can help Wikipedia by expanding it. |
